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T-cell receptor (TCR) cross-linking increases tyrosine phosphorylation of multiple proteins, only a few of
which have been identified. One of the most rapidly tyrosine-phosphorylated polypeptides is the 120-kDa
product of the proto-oncogene c-cbl, a cytosolic and cytoskeletal protein containing multiple proline-rich motifs
that are potential binding sites for proteins containing Src homology 3 (SH3) domains. We report here that in
cultured Jurkat T cells, Cbl is coprecipitated with antibody against the adapter protein Grb2. Upon activation
of Jurkat T cells via the TCR-CD3 complex, we find that high-affinity binding of Cbl requires the N-terminal
SH3 domain of GST-Grb2 fusion protein but after cross-linking of the TCR-CD3 and CD4 receptors, Cbl binds
equally to its SH2 domain. Grb2 antisera also precipitated p85 from serum-starved cells, while TCR activation
increased p85 and tyrosine-phosphorylated Cbl but not Cbl protein in Grb2 immunocomplexes. Phosphati-
dylinositol (PI) 3-kinase activity was immunoprecipitated from serum-starved cells with Cbl and to a lesser
extent with Grb2 antisera, and TCR cross-linking increased this activity severalfold. The PI 3-kinase activity
associated with Cbl amounted to 5 to 10% of the total cellular activity that could be precipitated by p85
antisera. The Ras exchange factor Son-of-sevenless 1 (Sos-1) was not found in anti-Cbl immunoprecipitates
from activated cells, and Cbl was not detectable in anti-Sos-1 precipitates, supporting the likelihood that
Sos-Grb2 and Cbl-Grb2 are present as distinct complexes. Taken together, these data suggest that Cbl function
in Jurkat T cells involves its constitutive association with Grb2 and its recruitment of PI 3-kinase in response
to TCR activation.
A major signaling pathway involved in regulating T-lympho-
cyte proliferation and other functions is a PTK-dependent
tyrosine phosphorylation cascade for recruiting proteins to the
TCR-CD3 complex (47). The importance of this pathway is
underscored by the ability of PTK inhibitors to block signal
transduction, PI turnover, and Ca21 release (29, 35). Although
protein tyrosine phosphorylation is a critical early event that
determines the selectivity of the signaling pathway, the TCR
does not possess intrinsic PTK or protein tyrosine phosphatase
activity (47). Receptor cross-linking increases the activity of
p56lck and p59fyn(T), both members of the Src PTK family
containing Src homology 2 (SH2) and SH3 domains (22). SH2
domains consist of segments of approximately 100 amino acids
that bind particular phosphotyrosine residues, while SH3 do-
mains are 60-amino-acid segments that bind to proline-rich
motifs having the consensus amino acid PXXP (20, 26). The
lymphocyte isoform of Fyn binds to subunits of the TCR-CD3
complex (36). Lck, a T-cell specific PTK, binds to the CD4
coreceptor and is itself activated, an event which may coincide
with tyrosine phosphorylation of the TCR (35, 41). Syk, a
member of the Syk/ZAP 70 PTK family, is believed to be the
proximal PTK that becomes phosphorylated upon TCR cross-
linking (8, 15). Syk binds to the TCR-CD3 complex via SH2-
phosphotyrosine interactions at certain residues having the
general sequence Y-X2-L-X7-Y-X2-I/L (32, 37). Evidence sug-
gests that both tyrosine residues in these tyrosine activation
motifs must be phosphorylated to allow coupling to the SH2
domains of these proteins (47).
While multiple cellular proteins in T lymphocytes are phos-
phorylated on tyrosine residues as a result of PTK activation
(17), relatively few have as yet been identified. Phospholipase
Cg1 is tyrosine phosphorylated and activated following TCR-
CD3 cross-linking, resulting in the formation of diacylglycerol
and inositol 1,4,5-trisphosphate, which increase the protein
kinase C activity and intracellular Ca21 content, respectively
(46). A protein that may be associated with phospholipase Cg1
in activated T cells is pp36-38, which becomes tyrosine phos-
phorylated and binds to the SH2 domain of Grb2 after activa-
tion (39). Grb2, a protein composed of two SH3 domains and
one SH2 domain, links receptor/nonreceptor PTK to p21ras
pathways by complexing with the guanine nucleotide exchange
proteins Sos-1 and Sos-2. A fraction of the cellular pool of Sos
is bound stably to Grb2 by interaction with the N-terminal SH3
domain (10, 34). Shc is another widely expressed SH2-contain-
ing protein that becomes tyrosine phosphorylated in response
to a variety of growth factors and associates with the SH2
domain of Grb2, which in turn binds Sos-1 (27). Shc has been
reported to complex with Grb2-Sos and to the phosphorylated
zeta-C motif after activation (29), although the stoichiometry
of Shc tyrosine phosphorylation and association with Grb2 is
low in T lymphocytes (39). Another possible substrate for Grb2
is a 75-kDa protein that becomes tyrosine phosphorylated after
receptor cross-linking, and binds in vitro to the SH3 domains
of a Grb2 fusion protein (31).
A major phosphotyrosine-containing protein band of 120
kDa that binds to SH3 and SH2 domains of Lck, Fyn, Src, p85,
and Grb2 in vitro has been observed by several groups, includ-
ing our laboratory, studying T-cell activation (21, 25, 30).
While the present work was in progress, the 120-kDa tyrosine-
phosphorylated protein that binds to Grb2 SH3 domains in
vitro in T cells was identified as the product of the proto-
oncogene c-cbl (9). Cbl is a 906-amino-acid protein that is
distributed in cytosol and cytoskeletal compartments and con-
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tains 17 proline-rich motifs in the C terminus with potential to
bind SH3 domains (6). The viral oncogene product, v-Cbl, is a
severely truncated C-terminal form, localized in both the cy-
toplasm and the nucleus, where it can bind to DNA. This
truncated form of Cbl may therefore act as a transcription
factor. Although a truncated nuclear protein encoded by c-cbl
has been proposed to exist (6), no such protein has been
identified in the nucleus as yet.
The fact that Cbl associates with GST-Grb2 in cell-free
systems (8) suggests the possibility that it is involved in the
function of Sos or other proteins that also interact with Grb2.
The aim of the present studies was to evaluate the mechanism
of Grb2 binding to Cbl in activated Jurkat T cells as well as its
potential relationship to the p21ras and PI 3-kinase pathways.
We report here that Cbl is indeed associated with both Grb2
and p85 in intact Jurkat cells and that immunocomplexes of
Cbl contain PI 3-kinase activity that is activated three- to four-
fold upon TCR cross-linking. Furthermore, our data indicate
that the Grb2 bound to Cbl in intact cells is not available to
associate with Sos-1.
MATERIALS AND METHODS
Abbreviations used in this paper. BSA, bovine serum albumin; GST, gluta-
thione S-transferase; HEPES, N-2-hydroxyethylpiperazine-N9-2-ethanesulfonic
acid; HRP, horseradish peroxidase; Ig, immunoglobulin; IRS, insulin receptor
substrate; MAb, monoclonal antibody; PI, phosphatidylinositol; PTK, protein
tyrosine kinase; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis; SH, Src homology; Sos, son of Sevenless; TCR, T-cell receptor.
Antibodies and reagents. A fusion protein, GST-p85SH2, comprising both
SH2 domains of p85 from nucleotides 986 to 2313, was made by PCR amplifi-
cation of human p85 alpha cDNA with the primers 59-CTACTGGATCCAA
CAACGGTATG-39 (sense) and 59-CAGCGGAATTCACAGATCAGACTG-39
(antisense) followed by cloning into pGEX2T. The correct sequence was verified
by double-strand sequencing. After transfection into Escherichia coli XA90, the
fusion protein was affinity purified on glutathione-agarose beads (Sigma) from
the Triton X-100-soluble fraction after induction with b-D-thiogalactopyrano-
side. A Sos-1 C-terminal polyclonal antibody was made by PCR amplification of
mSos-1 (amino acids 1230 to 1333) with the primers 59-CCATTACGGATC
CAACCTCCTCC-39 (sense) and 59-GAAGAATTCGCATTCTCCAGC-39 (an-
tisense) and ligated into pGEX3X, and the expressed fusion protein was injected
into rabbits. The anti-Grb2 polyclonal antibody was made by immunizing rabbits
with a full-length GST-Grb2 fusion protein. Human GST-Grb2, GST-P49L Grb2
(SH3 mutant), and GST-R86K Grb2 (SH2 mutant) were gifts from J. Schless-
inger. Polyclonal Cbl antibody was purchased from Santa Cruz Inc., and p85
antibody was purchased from UBI, Lake Placid, N.Y. The Grb2 MAb was from
Transduction Labs, and antiphosphotyrosine MAb 4G10 was from UBI. HRP-
conjugated rabbit anti-sheep IgG-HRP was from Zymed; rabbit anti-mouse
IgG-HRP and protein A-HRP were from Amersham. HRP was detected by
chemiluminescence (Boehringer Mannheim). OKT3 and OKT4 MAbs were pu-
rified from cell culture supernatants by passage over protein G-sepharose in a
high-salt buffer (13).
Cell culture. The Jurkat cell line E6-1, obtained from the American Type
Culture Collection, was grown in RPMI 1640 supplemented with 7% fetal calf
serum (Gibco), 2 mM glutamine, 10 mM HEPES (pH 7.4), 50 mM 2-mercapto-
ethanol, and penicillin/streptomycin. Hybridoma cells producing anti-CD3e
MAb OKT3 and anti-CD4 MAb OKT4 were obtained from the American Type
Culture Collection and grown in Dulbecco’s modified Eagle’s medium plus 20%
fetal calf serum.
Cell stimulation and preparation of cell lysates. Cells were grown to a density
of 106/ml, centrifuged, and serum starved in serum-free RPMI 1640 for 4 h. Cells
were resuspended at 5 3 107/ml in serum-free RPMI 1640 at 48C. CD3 and CD4
receptors were bound to 10 mg of OKT3 and OKT4 per ml at 48C for 10 min; this
was followed by cross-linking with a fourfold excess of anti-mouse IgG (Cappel)
for 10 min at 48C. Cells were heated at 378C for 2 min; washed immediately in
cold phosphate-buffered saline containing 0.5 mM Na3VO4, 5 mM EDTA, and
10 mM NaF; and lysed with 1% Nonidet P-40 in buffer A (10 mM Tris [pH 7.5],
1 mM EDTA, 150 mM NaCl, 1 mM vanadate, 0.1 mM phenylmethylsulfonyl
fluoride, and 25 mg of aprotinin per ml) for 15 min at 48C. Nuclei were removed
by centrifugation at 12,000 3 g for 4 min. Cells activated with OKT3 received
only OKT3 (10 mg/ml) and nonstimulated cells were incubated with anti-IgG (80
mg/ml) before being heated at 378C for 2 min.
Immunoprecipitation and blotting. Lysates were cleared with 2 to 5 ml of
preimmune serum per 107 cell equivalents and bound to protein A-Sepharose for
15 min at 48C. After centrifugation, supernatants were mixed with 2 to 5 ml of
primary antibody per 107 cells plus protein A- or G-Sepharose for 1 h at 48C.
Beads were washed successively with 0.2% Nonidet P-40 in buffer A, 0.5 M NaCl
in buffer A, and 10 mM Tris (pH 7.5) and solubilized by being boiled for 5 min
in SDS-PAGE sample buffer. Proteins were separated in 7 or 12% SDS-PAGE
minigels (Bio-Rad), transferred onto nitrocellulose filters (Schleicher & Schuell,
Keene, N.H.) by electroblotting for 3 h at 300 mA, and blocked in either 1% BSA
(antiphosphotyrosine blots) or 5% dry milk, plus buffer B (10 mM Tris [pH 7.5],
100 mM NaCl, 0.1% Tween 20). All primary antibodies were added in buffer B
at 1 mg/ml, except 4G10, which was used at 0.25 mg/ml, for 1 to 2 h. Secondary
antibodies were added at 0.02 to 0.1 mg/ml, and the filters were washed exten-
sively and visualized by chemiluminescence.
Far Western blots. Nitrocellulose filters containing resolved proteins were
denatured in buffer C (25 mM NaCl, 5 mM MgCl2, 25 mM HEPES [pH 7.9], 1
mM dithiothreitol) plus 6 M guanidine for 15 min at 48C. Proteins were gradually
renatured in buffer C, blocked in 1% BSA, and hybridized at 48C overnight with
GST-Grb2 fusion protein (1 mg/ml). Detection was performed with anti-GST
antibody followed by chemiluminescence.
Binding with fusion proteins. Lysates (107 cell equivalents) were incubated
with 10 mg of GST fusion protein (quantitated by Coomassie blue staining with
a range of BSA standards) plus glutathione-agarose as carrier for 1 h at 48C. The
beads were washed as described above.
PI 3-kinase activity assay. PI 3-kinase activity was measured as described
previously (4) with immunoprecipitates of lysates from 107 cell equivalents, 1
mM plant PI plus phosphatidylserine as the substrate, and 10 mM [32P]ATP (25
Ci/mmol). The labeled lipid products were separated by thin-layer chromatog-
raphy on silica gel plates and quantitated by exposure on a Betascope (Betagen).
RESULTS
Protein tyrosine phosphorylation is an early event in T-
lymphocyte signaling and can be induced to different degrees
by cross-linking of the CD4 and CD3-TCR receptors (17). In
Fig. 1, serum-starved Jurkat cells were activated with the CD4
antibody OKT4 or the CD3 antibody OKT3 or by adding both
antibodies and cross-linking them with anti-IgG. Tyrosine
phosphorylation in Jurkat T cells was maximal when the OKT3
and OKT4 antibodies were cross-linked with anti-IgG (lane 5)
and weaker when only the CD3 receptor was activated (lane 3).
Cross-linking of OKT3 and OKT4 antibodies on Jurkat cells
initiated a pronounced phosphorylation of multiple proteins,
including a prominent band at 120 kDa, within 2 min. Stimu-
lation was transient and diminished considerably by 10 min.
Several reports have noted that various SH2 domains bind to
a 115- to 120-kDa protein in hematopoietic cells. For example,
a 120-kDa protein complexes in vitro with SH2 domains of Fyn
FIG. 1. Tyrosine phosphorylation in Jurkat T cells activated via the CD3 and
CD4 receptors. Cells were serum starved in RPMI 1640 for 4 h and resuspended
in serum-free RPMI 1640 at 5 3 107 cell equivalents per ml. (A) Cells were
activated as indicated with 10 mg each of OKT3 and OKT4 and 80 mg of
anti-mouse IgG at 378C for 2 min. (B) Cells were activated with OKT3–OKT4–
anti-IgG for the times indicated, washed in PBS, and lysed in 1% Nonidet P-40.
Approximately 5 3 105 cell equivalents of total-cell lysate were loaded per lane,
electrophoresed, and, after transfer to nitrocellulose, blotted with antiphospho-
tyrosine (anti-PY) antibody 4G10. Detection was performed by chemilumines-
cence.
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and Lyn after activation of T cells (30), and a 116-kDa ty-
rosine-phosphorylated protein becomes tightly coupled to
p85/PI 3-kinase after anti-IgG cross-linking of the monocytic
cell line U937 (24). We therefore examined whether a GST-
Grb2 fusion protein or one containing both SH2 domains of
p85 bind to a common 120-kDa protein. Figure 2 shows that
both fusion proteins bound a phosphotyrosine protein of 120
kDa from lysates of activated cells (lanes 1 to 4). When GST-
p85SH2 was added to supernatants from GST-Grb2-depleted
lysates (lane 5), no 120-kDa polypeptide was adsorbed. How-
ever, GST-Grb2 was able to bind a population of tyrosine-
phosphorylated p120 that was not reactive with GST-p85SH2
(lane 6). Thus, both proteins were bound to the same p120
polypeptide, although the GST-Grb2 fusion protein recog-
nized in addition a subfraction of tyrosine-phosphorylated
p120 that was not bound by GST-p85SH2.
Donovan et al. (9) have reported that the 120-kDa tyrosine-
phosphorylated protein that binds to a GST-Grb2 fusion pro-
tein in activated Jurkat cells is the product of the proto-onco-
gene c-cbl. The p120 protein identified in our studies (Fig. 1
and 2) was also found to be Cbl (Fig. 3). Lysates from resting
and stimulated Jurkat cells were immunoprecipitated with Cbl,
Grb2, or p85 antisera and blotted against Cbl, 4G10, or p85
antisera. All antisera precipitated a protein of the same size
that was recognized by Cbl antiserum but was not present in
precipitates of nonimmune rabbit serum. The amount of Cbl
found in Grb2 immunoprecipitates was not affected by activa-
tion (lanes 6 and 7), whereas the amount bound to p85 was
increased (lanes 4 and 5). The antiphosphotyrosine blot reveals
that receptor cross-linking increased the amount of tyrosine-
phosphorylated Cbl immunoprecipitated with anti-p85 (lanes 4
and 5) and anti-Grb2 (lanes 6 and 7). Activation of Jurkat cells
resulted in a noticeable shift in the intensity of a doublet band
in anti-Cbl blots of p85 and Grb2 immunoprecipitates (lanes 4
to 7) and may correspond to two populations of differentially
phosphorylated Cbl. The bottom panel shows that Cbl and
Grb2 antisera coprecipitate p85 and that activation increases
the amount bound to both of these proteins (lanes 6 to 9).
Thus, Grb2 and p85 are bound in vivo to Cbl, and activation
results in an increase in the amount of p85 in this complex.
The role of Src family SH3 domains in binding a tyrosine-
phosphorylated 120-kDa protein in activated T cells has been
well documented (25, 30), and this protein has been identified
recently as Cbl (9). In the present study, the affinity of p120/Cbl
in Jurkat cells for the SH2 and SH3 domains of Grb2 was
tested by binding a native GST-Grb2 fusion protein or GST-
Grb2 proteins with an inactivating mutation in the N-terminal
SH3-binding domain (P49L) or SH2-binding domain (R86K).
Figure 4 (top) shows that after fully activating Jurkat cells by
cross-linking the CD3 and CD4 receptors, a tyrosine-phospho-
rylated 120-kDa protein bound with equal affinity to GST-
Grb2, GST-P49L, and GST-R86K between 0.2 and 10 mg of
the GST fusion proteins. Blotting the fusion protein precipi-
tates for Cbl yielded identical results, indicating that the stoi-
chiometries of tyrosine phosphorylation of the 120-kDa pro-
tein recognized by the native and mutant Grb2 fusion proteins
are similar and that this protein is Cbl. In experiments not
illustrated, tyrosine-phosphorylated pp36-38 (39) did not bind
to GST-R86K (mutated SH2) and the Ras exchange factor
mSos-1 was not complexed to GST-P49L (mutated N-SH3),
confirming that both point mutations were functionally unable
to react with their known substrates in activated cells (10, 34).
Previous results (21) showed that in OKT3-stimulated cells,
GST-P49L bound less Cbl than did the native GST-Grb2 pro-
tein. Figure 4 (bottom two panels) confirms this result by
showing the dose-response relationship of GST-Grb2 fusion
protein binding to Cbl, using lysates of Jurkat cells that were
activated with 10 mg of OKT3 only. It is evident that although
wild-type GST-Grb2 and GST-R86K showed similar apparent
high affinities and capacities for binding Cbl, the amount of Cbl
bound by the P49L mutant was greatly reduced. Significant
binding of Cbl to GST-P49L was seen only above 2.5 mg of
protein. Thus, in the fully activated state, Cbl can bind with
high affinity to either the SH2 or SH3 domains of Grb2; how-
ever, in the partially tyrosine-phosphorylated state (OKT3
cross-linking only) or in nonactivated cells, the N-terminal SH3
domain is necessary to bind similar amounts of Cbl.
FIG. 2. Grb2-GST and p85-GST fusion proteins bind to the same p120
tyrosine-phosphorylated protein in activated Jurkat T cells. Lysates from 107
cells activated by cross-linking with OKT3 and OKT4 were incubated at 48C with
10 mg of GST-Grb2 (lane 1) or 10 mg of GST-p85SH2 (lane 3) for 1 h. After
centrifugation, supernatants from the GST-Grb2 binding were mixed again with
10 mg of either GST-Grb2 (lane 2) or GST-p85SH2 (lane 5); the GST-p85SH2
supernatants were mixed with GST-p85SH2 (lane 4) or GST-Grb2 (lane 6) for an
additional 1 h. All pellets were washed and resuspended in SDS sample buffer.
Samples were electrophoresed in 7% acrylamide, transferred to nitrocellulose,
blotted with the antiphosphotyrosine (anti-PY) antibody 4G10, and detected by
chemiluminescence.
FIG. 3. The tyrosine-phosphorylated p120 protein in Jurkat cells that immu-
noprecipitates with Grb2 and p85 is Cbl. Lysates from unstimulated and fully
activated cells (107 cell equivalents) were precleared with normal rabbit serum-
protein A Sepharose before immunoprecipitation with normal sera (lane 3),
anti-p85 (lanes 4 and 5), anti-Grb2 (lanes 6 and 7); or anti-Cbl (lanes 8 and 9).
Lanes 1 and 2 are total-cell lysates of 53 105 cells. Following electrophoresis and
transfer to nitrocellulose, samples were probed with Cbl (top), the antiphospho-
tyrosine (anti-pY) antibody 4G10 (middle), or p85 (bottom) antiserum and
visualized by chemiluminescence.
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It is likely that Grb2 and Cbl form stable complexes in intact
cells through binding the N-terminal SH3 domain of Grb2 to
proline-rich motifs in the C terminus of Cbl (9, 33). In view of
the apparent high affinity of the Grb2 SH2 domain for Cbl
(Fig. 4, top panels), we examined whether Grb2 SH2 was
bound directly to Cbl by boiling cell lysates in 0.5% SDS to
dissociate preformed complexes, diluting them 10-fold in 0.2%
Nonidet P-40, and then incubating them with 10 mg of GST-
Grb2 fusion proteins. In Fig. 5, the antiphosphotyrosine blot of
adsorbed proteins shows that boiling samples in SDS had no
effect on the binding of Cbl to full-length GST-Grb2 (lanes 2,
3, 8, and 9) or to the SH2 mutant GST-R86K (lanes 6, 7, 12,
and 13). Boiling also had no effect on the binding of Cbl to the
SH3 mutant GST-P49L after Jurkat cell activation (lanes 5 and
11) but reduced the association in lysates from serum-starved
cells (lanes 3 and 10). These data are consistent with the
possibility that the SH2 domain of Grb2 binds directly to Cbl,
at least in activated cells. This conclusion is strengthened by
the data in Fig. 6, which is a far Western blot of proteins in cell
lysates bound to GST or GST-Grb2. After electrophoresis and
transfer of resolved proteins to a nitrocellulose filter and re-
naturation, the membrane was probed with either Grb2 (Fig. 6,
top) or the P49L mutant protein (Fig. 6, bottom). Both pro-
teins were bound to the same 120-kDa band that was also
recognized by Cbl antiserum (arrow). The identity of the more
slowly migrating band recognized by GST-Grb2 (top, lanes 3
and 4) is unknown, but it is likely to be a different Grb2-SH3-
binding protein.
Ward et al. (45) have observed an increase in cellular 39-
phosphorylated polyphosphoinositides following TCR cross-
linking. The binding of p85 to Cbl that we have observed (Fig.
3) raised the possibility that CD3-CD4 receptor ligation is
accompanied by an increase in PI 3-kinase activity in the Cbl-
p85 complex. PI 3-kinase activity was measured by immuno-
precipitating lysates of resting and TCR-cross-linked Jurkat
cells with antisera to p85, Grb2, and Cbl and resolving the
[g-32P]ATP incorporated into PI 39-phosphate by thin-layer
chromatography (Table 1; Fig. 7). After TCR cross-linking,
total PI 3-kinase activity immunoprecipitated with p85 antisera
increased about twofold, but it rose fourfold in Cbl immuno-
complexes and to a similar extent in Grb2 immunoprecipitates.
FIG. 4. The affinity of Cbl for Grb2 SH2 and SH3 domains is dependent
upon the extent of CD3 and CD4 receptor cross-linking in Jurkat cells. (Top)
Lysates from 107 cells activated with OKT3–OKT4–anti-IgG were mixed for 1 h
with the indicated amount of GST-Grb2, GST-P49L (-SH3), or GST-R86K
(-SH2), plus glutathione-agarose as required, washed, and solubilized in SDS
sample buffer. (Bottom) Cells were activated with 10 mg of OKT3 per ml for 2
min, and lysates were mixed with the GST-Grb2 proteins as indicated. After
electrophoresis and transfer to nitrocellulose, membranes were blotted with the
antiphosphotyrosine (anti-PY) antibody 4G10 or anti-Cbl and detected by
chemiluminescence. The concentrations of the GST fusion proteins were esti-
mated by comparison with Coomassie blue-stained BSA standards.
FIG. 5. Grb2 SH2 and SH3 domains bind directly to Cbl in activated Jurkat
cells. Lysates from unstimulated and fully activated cells (107 cell equivalents)
were boiled for 5 min in 0.5% SDS (lanes 8 to 13) and cooled to 48C. All lysates
were diluted 10-fold in 1% Nonidet P-40 lysis buffer, mixed with 10 mg of protein
for 1 h, and washed, and SDS sample buffer was added. Following electrophore-
sis and transfer to nitrocellulose, samples were probed with 4G10 MAb and
visualized by chemiluminescence.
FIG. 6. The GST-Grb2 SH3 mutant binds directly to Cbl in a far Western
blot. Lysates from unstimulated and fully activated cells (107 cell equivalents)
were bound to 10 mg of GST or GST-Grb2. After electrophoresis and transfer to
nitrocellulose, samples were subjected to denaturation-renaturation, probed with
GST-Grb2 or GST-P49L (1 mg/ml) followed by anti-GST antibody, and visual-
ized by chemiluminescence. The band corresponding to Cbl (arrow) was detected
by stripping the filter and reprobing with the anti-Cbl antibody.
TABLE 1. TCR cross-linking increases PI 3-kinase
activity associated with Cbla
Antiserum
PI 3-kinase activity (%)b
Unstimulated OKT3-OKT4
p85 100 192 6 11
Cbl 4.5 6 0.5 19.5 6 6.2
Grb2 0.46 6 0.11 1.40 6 0.46
a For experimental details, see the text and the legend to Fig. 7.
b Sample radioactivity was quantified by exposure on a Betascope and is
expressed as the percentage of PI 3-phosphate in p85 immunoprecipitates, which
averaged 1,090 cpm. Data are the mean 6 standard deviation from three exper-
iments performed in duplicate.
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The small amount of PI 3-kinase activity complexed to Grb2
probably represents an underestimate, since our anti-Grb2 an-
tibody does not immunoprecipitate all of the cellular Grb2.
However, the amount of Cbl and p85 antisera used for the
immunoprecipitations depleted Cbl and p85 from cell lysates
virtually completely, as judged by analysis of postantibody su-
pernatants by SDS-PAGE followed by Western blotting (data
not shown). Therefore, the data in Table 1 and Fig. 7 suggest
that 5 to 10% of the total PI 3-kinase activity in Jurkat cells is
associated with Cbl in a TCR activation-dependent manner.
The evidence presented in Fig. 5 and 6 suggesting that the
Grb2 SH2 domain binds directly to Cbl raised the possibility
that Sos, which binds predominantly to the N-terminal SH3
domain of Grb2, forms a trimeric complex with Cbl. To exam-
ine this, T-cell lysates were immunoprecipitated with mSos-1
and Cbl antisera, and after electrophoresis, the nitrocellulose
membrane was probed for the presence of Cbl, Sos-1, or Grb2
(Fig. 8). Although Sos-1 and Cbl antisera recognized their
respective epitopes at 170 and 120 kDa in total-cell lysates and
immunoprecipitates, no Sos-1 was found in Cbl precipitates
(lanes 5 and 6) and Cbl was not present in Sos precipitates
(top, lane 4). The bottom panel of Fig. 8 shows that both
antisera immunoprecipitated Grb2, although more Grb2 was
present in Cbl than in Sos immunoprecipitates (lanes 4 to 6). A
comparison of antisera raised against the N-terminal, catalytic,
and C-terminal regions of Sos showed that all antibodies im-
munoprecipitated equivalent amounts of Grb2 (results not il-
lustrated). We also tested whether Sos-1 complexed to Cbl and
Grb2 by comparing the amounts of pp36 and Cbl bound to
GST-Grb2 or GST-Sos C-terminal fusion proteins. pp36 is a
membrane-bound tyrosine-phosphorylated protein that binds
to Grb2 SH2 domains, presumably bringing the Grb2-Sos com-
plex into the proximity of Ras (39). Figure 9 (lanes 5 and 6)
confirms that tyrosine-phosphorylated pp36 was bound to
Grb2 in an activation-dependent manner. Although the Sos
C-terminal fusion protein also bound to tyrosine-phosphory-
lated pp36 (lanes 3 and 4), Cbl was associated only with the
GST-Grb2 fusion protein and not with Sos (top, lanes 3 to 6).
These data support the likelihood that Sos-Grb2 and Cbl-Grb2
are present as distinct complexes in T cells.
DISCUSSION
We show here that upon CD3-CD4 receptor cross-linking in
Jurkat cells, a major tyrosine-phosphorylated protein of 115 to
120 kDa binds to Grb2 and p85 and that this protein cross-
reacts with antisera to the product of the proto-oncogene c-cbl
(Fig. 3). Immunoprecipitation with Cbl antiserum completely
removes the 120-kDa band, confirming that the only observ-
able tyrosine-phosphorylated protein in this size range is Cbl
(results not illustrated). Recently, Donovan et al. (9) have
reported that GST-Grb2 binds to Cbl stably via the N-terminal
but not the C-terminal SH3 domain, and Rivero-Lezcano et al.
(33) showed that Nck SH3 groups bind to Cbl in vitro. Our
FIG. 7. TCR cross-linking increases PI 3-kinase activity associated with Cbl.
Serum-starved cells were activated for 2 min by cross-linking with OKT3 and
OKT4 antisera. Lysates from 107 cell equivalents of unstimulated (lanes 2 to 4)
and fully activated cells (lanes 1 and 5 to 7) were mixed for 1 h with 1 mg of
antiserum and, after being washed, incubated with [g-32P]ATP plus 1 mM PI–
phosphatidylserine as described in Materials and Methods. Samples were ex-
tracted with chloroform-methanol, and the PI 3-phosphate (PI3P) was resolved
by thin-layer chromatography and visualized by autoradiography. Sample radio-
activity was quantified by exposure on a Betascope. A representative autoradio-
gram is shown.
FIG. 8. Cbl binds to Grb2 but not to Sos-1 in intact Jurkat cells. Lysates from
107 unstimulated (lanes 1 and 5) or fully activated cells (lanes 2 to 4 and 6) were
precleared with normal rabbit serum before addition of normal serum (lane 3),
Sos-1 antiserum (lane 4), or Cbl antiserum (lanes 5 and 6). Following electro-
phoresis and transfer to nitrocellulose, samples were probed with anti-Cbl (top),
anti-Sos (middle), or anti-Grb2 (bottom) and visualized by chemiluminescence.
Lanes 1 and 2 are total-cell lysates from 5 3 105 cells.
FIG. 9. A C-terminal GST-Sos fusion protein binds pp36 but not Cbl in
activated T cells. Lysates from resting (lanes 1, 3, and 5) or OKT3-OKT4-cross-
linked (lanes 2, 4, and 6) cells were bound to 10 mg of a GST (lanes 1 and 2),
GST-Sos C-terminal (lanes 3 and 4), or GST-Grb2 (lanes 5 and 6) protein, and,
after SDS-PAGE with 12% (bottom) or 7% (top) polyacrylamide, probed with
the antiphosphotyrosine (anti-PY) antibody 4G10.
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data are consistent with these reports in that the GST-R86K
mutant of Grb2 lacking the SH2 domain binds Cbl with high
affinity and capacity in Jurkat cell lysates (Fig. 4). We further
show that the ability of Cbl to bind this mutant GST-Grb2
fusion protein is similar in partially stimulated (OKT3) and
fully activated (cross-linked OKT3 plus OKT4) cells. Thus, the
N-terminal SH3 domain of Grb2 apparently binds to Cbl in-
dependently of its state of tyrosine phosphorylation, consistent
with its predicted binding to one or more of the proline-rich
motifs in the COOH terminus of Cbl.
Our results also show that a mutant Grb2 lacking a func-
tional N-SH3 domain binds little Cbl in lysates of resting cells
or OKT3-stimulated cells but that complete cross-linking of
cellular CD3-CD4 receptors markedly enhances Cbl binding to
this mutant (Fig. 4). These data may explain the reported
binding of a 115- to 120-kDa tyrosine-phosphorylated protein
to GST-Grb2 but not to the SH3 mutant of Grb2 in T cells
activated with OKT3 (21). Also consistent with the data pre-
sented here are reports that in T cells activated with OKT3, a
120-kDa tyrosine-phosphorylated protein is bound more
tightly to Fyn or Lck fusion proteins containing both SH do-
mains than to the SH3 domain alone (25, 30). If, as seems
likely, the tyrosine-phosphorylated p120 protein described in
these reports is Cbl, the requirement for both SH2 and SH3
domains in other adapter molecules such as Nck or Crk may be
dependent upon the extent of TCR cross-linking, as well. Our
data are consistent with the concept that cross-linking CD3
and CD4 receptors leads to increased tyrosine phosphorylation
of one or more sites on Cbl that bind the SH2 domain of Grb2.
We have presented evidence by far Western blotting (Fig. 6)
and by SDS denaturation (Fig. 5) that the SH2 domain of Grb2
may be directly involved in binding to Cbl. For example, dis-
sociation of preformed complexes by boiling in SDS followed
by renaturation has little effect on binding of the SH3-deficient
mutant of Grb2 in lysates prepared from fully activated cells.
However, the phosphotyrosine motif in peptides recognized by
the Grb2 SH2 domain (pY-X-N-Y/Q) (5, 40) is not found in
any of the tyrosine residues in Cbl (7). Perhaps increased
tyrosine phosphorylation of Cbl might enhance the affinity of a
noncanonical tyrosine-phosphorylated site for the SH2 domain
of Grb2. However, no definitive data showing that the SH2
domain of Grb2 actually binds to Cbl in intact cells are yet
available. It also cannot be ruled out that the C-terminal SH3
domain, which fails to bind Cbl (9), can function to some
extent as part of intact Grb2.
Grb2 forms a stable complex in vivo with about 50% of the
pool of Cbl (Fig. 3). In the resting state, Cbl may also stably
associate with other SH3-containing proteins, such as Lck, Fyn,
and Src (21, 25, 30, 31). In a similar manner, Grb2 exists in
different intracellular complexes, each complex having a dis-
crete function. It is likely that the SH3-binding proteins dy-
namin (38) and C3G (42) bind stably to Grb2 and therefore
compete with Cbl for the cellular pool of Grb2. The Ras GTP
exchange protein Sos is known to be stably associated with
Grb2 through SH3-proline interactions (10, 34). The sequence
P494PVPPPR in Cbl is identical to a motif in the C-terminus of
Sos that binds Grb2 (19) and may serve as a competitive
binding site. Cbl has been reported to be an inhibitor of Sem-5
(Grb2)–Sos binding in Caenorhabditis elegans (35a). Evidence
presented here is consistent with the concept that Sos-Grb2
and Cbl-Grb2 form distinct complexes in T cells (Fig. 8 and 9).
It is possible that the association of Cbl or Grb2 with the
various SH2- or SH3-containing molecules allows these com-
plexes to be localized in different subcellular fractions.
A prominent consequence of TCR cross-linking is the bind-
ing of p85 to Cbl and a corresponding increase in associated PI
3-kinase activity (Fig. 3 and 7; Table 1). The small amount of
PI 3-kinase activity we have observed in Grb2 immunoprecipi-
tates may represent the fraction of p85 bound to Grb2 as a
trimeric complex, either with Cbl or with the protein tyrosine
kinases Fyn and Lck (28, 43), rather than in a direct associa-
tion. This conclusion is supported by the observation that
[32P]GST-Grb2 binds to Cbl but not to p85 in a far Western
blot (Fig. 6). However, we have not yet been able to define
rigorously whether small amounts of trimeric Grb2–Cbl–PI
3-kinase complexes actually exist. The sequence Y739EAM in
Cbl forms a possible recognition site for p85 SH2 binding,
although Shc can also bind to this consensus motif (40). In the
IRS-1 signaling complex found in insulin-sensitive cells, bind-
ing of p85 SH2 domains to IRS-1 after insulin stimulation
increases the associated PI 3-kinase activity 20-fold (3). Exley
et al. (11) have shown that the zeta chain of the TCR binds PI
3-kinase and that receptor cross-linking increases the activity
nearly threefold. These data suggest that the degree to which
PI 3-kinase is activated may depend upon the number of SH2-
binding motifs that are available for p85 association. IRS-1
contains eight proven sites (23), the TCR zeta chain has two
(11), whereas Cbl apparently has a single site. In addition to
SH2 domains, PI 3-kinase can bind to SH3 domains of p56lck
and p59fyn(T) in a phosphotyrosine-independent manner via a
proline-rich motif on p85, leading to the generation of phos-
phoinositide products (28, 43). The role of the N-terminal SH3
group of p85 in forming a stable complex with Cbl during
T-lymphocyte signaling is not known.
A variety of mitogenic and metabolic growth factors activate
PI 3-kinase, possibly by causing the p85 subunit to associate
with different tyrosine-phosphorylated proteins (2, 18). Recent
work suggests that the Saccharomyces cerevisiae PI 3-kinase
Vps34p regulates membrane trafficking and protein sorting
(14). It has also been demonstrated that PI 3-kinase binding to
the platelet-derived growth factor receptor is necessary for
trafficking of the activated receptor in the endocytic pathway
(16). The homology between the p110 catalytic subunit of
mammalian PI 3-kinase and S. cerevisiae Vps34p (14) suggests
that the Cbl–PI 3-kinase complex may have a role in protein
sorting.
Cbl shows certain structural and biochemical properties
similar to those of IRS-1, a 185-kDa protein found in insulin-
sensitive cells that mediates insulin receptor-PI 3-kinase acti-
vation. IRS-1 is a docking protein that is tyrosine phosphory-
lated by the insulin receptor and binds to SH2-containing
proteins such as Grb2, p85, and the protein tyrosine phos-
phatase SHPTP2, which in turn stimulate diverse signaling
pathways leading to selective mitogenic responses (23). My-
eloid progenitor cells also contain a second member of this
family, IRS-2, which becomes tyrosine phosphorylated upon
insulin and interleukin-4 stimulation and binds PI 3-kinase
(44). The sequence of c-Cbl (7) reveals 17 tyrosines, mostly
located in the N terminus, some containing canonical SH2-
binding motifs. In view of the multiple tyrosine residues and
the apparent high stoichiometry of its tyrosine phosphorylation
in fully activated T cells, Cbl may function as an SH2 docking
protein, allowing the formation of signaling complexes con-
taining different proteins. Evidence suggests that complexes of
Cbl with these proteins may be critical in regulating cell
growth. For example, overexpression of Cbl in NIH 3T3 cells,
while insufficient to induce transformation, nonetheless allows
cells to grow to a higher density (6). The demonstration that
v-cbl, which is a truncated form of c-cbl encoding a 355-amino-
acid N-terminal protein (7), enters the nucleus and is trans-
forming (6), indicates that a naturally cleaved c-Cbl protein is
found in the nucleus, in a manner similar to the processed form
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of the cytosolic p105 NF-kB precursor (12). To date, efforts to
locate such a truncated c-Cbl protein in the nucleus have not
been successful (1).
Lastly, we wish to point out that the distribution of cell
lineages containing proteins that react with Cbl antibodies is
not limited to hematopoietic cells. For example, Cbl was found
in HeLa cells (6), and we have observed a 120-kDa tyrosine-
phosphorylated protein recognized by Cbl antiserum in acti-
vated human kidney cells and mouse 3T3-L1 cells, suggesting
that this phosphoprotein may have a general role in signaling.
ACKNOWLEDGMENTS
This work was supported by Juvenile Diabetes Foundation Interna-
tional Program Project grant 892004 and a Juvenile Diabetes Founda-
tion International Fellowship (to B.R.C.).
We thank Judy Kula for excellent assistance in preparing the manu-
script.
REFERENCES
1. Andoniou, C., C. Thien, and W. Langdon. 1994. Tumour induction by acti-
vated abl involves tyrosine phosphorylation of the product of the cbl onco-
gene. EMBO J. 13:4515–4523.
2. Auger, K., L. Serunian, S. Soltoff, P. Lippy, and L. Cantley. 1989. PDGF-
dependent tyrosine phosphorylation stimulates production of novel poly-
phosphoinositides in intact cells. Cell 57:167–175.
3. Backer, J., M. Myers, S. Shoelson, D. Chin, K.-J. Sun, M. Miralpeix, P. Hu,
B. Margolis, E. Skolnik, J. Schlessinger, and M. White. 1992. Phosphatidyl-
inositol 39-kinase is activated by association with IRS-1 during insulin stim-
ulation. EMBO J. 11:3469–3479.
4. Baltensperger, K., L. Kozma, A. Cherniack, J. Klarlund, A. Chawla, U.
Banerjee, and M. P. Czech. 1993. Binding of the Ras activator son of
Sevenless to insulin receptor substrate-1 signaling complexes. Science 260:
1950–1952.
5. Batzer, A. G., D. Rotin, J. M. Uren˜a, E. Y. Skolnik, and J. Schlessinger. 1994.
Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor
receptor. Mol. Cell. Biol. 14:5192–5201.
6. Blake, T., K. Heath, and W. Langdon. 1993. The truncation that generated
the v-cbl oncogene reveals an ability for nuclear transport, DNA binding and
acute transformation. EMBO J. 12:2017–2026.
7. Blake, T., M. Shapiro, H. Morse, and W. Langdon. 1991. The sequences of
the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a
large truncation encompassing a proline-rich domain and a leucine zipper-
like motif. Oncogene 6:653–657.
8. Couture, C., G. Baier, A. Altman, and T. Mustelin. 1994. p56lck-independent
activation and tyrosine phosphorylation of p72syk by T-cell antigen receptor/
CD3 stimulation. Proc. Natl. Acad. Sci. USA 91:5301–5305.
9. Donovan, J., R. Wange, W. Langdon, and L. Samelson. 1994. The protein
product of the c-cbl protooncogene is the 120-kDa tyrosine-phosphorylated
protein in Jurkat cells activated via the T cell antigen receptor. J. Biol. Chem.
169:22921–22924.
10. Egan, S., B. Giddings, M. Brooks, L. Buday, A. Sizeland, and R. Weinberg.
1993. Association of Sos Ras exchange protein with Grb2 is implicated in
tyrosine kinase signal transduction and transformation. Nature (London)
363:45–51.
11. Exley, M., L. Varticovski, M. Peter, J. Sancho, and C. Terhorst. 1994.
Association of phosphatidylinositol 3-kinase with a specific sequence of the
T cell receptor zeta chain is dependent on T cell activation. J. Biol. Chem.
269:15140–15146.
12. Ghosh, S., A. Gifford, L. Riviere, P. Tempst, G. Nolan, and D. Baltimore.
1990. Cloning of the p50 DNA binding subunit of NF-kB: homology to rel
and dorsal. Cell 62:1019–1029.
13. Harlow, E., and E. Lane. 1988. Antibodies: a laboratory manual. Cold Spring
Harbor Laboratory Press, Cold Spring Harbor, N.Y.
14. Herman, P. K., and S. D. Emr. 1990. Characterization of VPS34, a gene
required for vacuolar protein sorting and vacuole segregation in Saccharo-
myces cerevisiae. Mol. Cell. Biol. 10:6742–6754.
15. Howe, L., and A. Weiss. 1995. Multiple kinases mediate T-cell-receptor
signaling. Trends Biochem. Sci. 20:59–65.
16. Joly, M., A. Kazlauskas, F. Fay, and S. Corvera. 1994. Disruption of PDGF
receptor trafficking by mutation of its PI-3 kinase binding sites. Science
263:684–687.
17. June, C., M. Fletcher, J. Ledbetter, and L. Samelson. 1990. Increases in
tyrosine phosphorylation are detectable before phospholipase C activation
after T cell receptor stimulation. J. Immunol. 144:1591–1599.
18. Kapeller, R., and L. Cantley. 1994. Phosphatidylinositol 3-kinase. Bioessays
16:565–576.
19. Li, N., A. Batzer, R. Daly, V. Yajnik, E. Skolnik, P. Chardin, D. Bar-Sagi, B.
Margolis, and J. Schlessinger. 1993. Guanine-nucleotide-releasing factor
hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling.
Nature (London) 363:85–88.
20. Mayer, B., and D. Baltimore. 1993. Signaling through SH2 and SH3 domains
Trends Cell Biol. 3:8–13.
21. Motto, D., S. Ross, J. Jackman, Q. Sun, A. Olson, P. Findell, and G.
Koretzky. 1994. In vivo association of GRB2 with pp116, a substrate of the
T cell antigen receptor-activated protein tyrosine kinase. J. Biol. Chem.
269:21608–21613.
22. Mustelin, T., and P. Burn. 1993. Regulation of src family tyrosine kinases in
lymphocytes. Trends Biochem. Sci. 18:215–220.
23. Myers, M., X.-J. Sun, and M. White. 1994. The IRS-1 signaling system.
Trends Biochem. Sci. 19:289–293.
24. Ninomiya, N., K. Hazeki, Y. Fukui, T. Seya, T. Okada, O. Hazeki, and M. Ui.
1994. Involvement of phosphatidylinositol 3-kinase in Fc gamma receptor
signaling. J. Biol. Chem. 269:22732–22737.
25. Panchamoorthy, G., T. Fukazawa, L. Stolz, G. Payne, K. Reedquist, S.
Shoelson, Z. Songyang, L. Cantley, C. Walsh, and H. Band. 1994. Physical
and functional interactions between SH2 and SH3 domains of the Src family
protein tyrosine kinase p59fyn. Mol. Cell. Biol. 14:6372–6385.
26. Pawson, T., and G. Gish. 1992. SH2 and SH3 domains: from structure to
function. Cell 71:359–362.
27. Pelicci, G., L. Lanfrancone, F. Grignani, J. McGlade, F. Cavallo, G. Forni,
I. Nicoletti, F. Grignani, T. Pawson, and P. Pelicci. 1992. A novel transform-
ing protein (SHC) with an SH2 domain is implicated in mitogenic signal
transduction. Cell 70:93–104.
28. Prasad, K., O. Janssen, R. Kapeller, M. Raab, L. Cantley, and C. Rudd.
1993. Src-homology 3 domain of protein kinase p59fyn mediates binding to
phosphatidylinositol 3-kinase in T cells. Proc. Natl. Acad. Sci. USA 90:7366–
7370.
29. Ravichandran, K., K. Lee, Z. Songyang, L. Cantley, P. Burn, and S. Bura-
koff. 1993. SHC interacts with the zeta chain of the T cell receptor upon T
cell activation. Science 262:902–904.
30. Reedquist, K., T. Fukazawa, B. Druker, G. Panchamoorthy, S. Shoelson, and
H. Band. 1994. Rapid T-cell receptor-mediated tyrosine phosphorylation of
p120, an Fyn/Lck Src homology 3 domain-binding protein. Proc. Natl. Acad.
Sci. USA 91:4135–4139.
31. Reif, K., L. Buday, J. Downward, and D. Cantrell. 1994. SH3 domains of the
adapter molecule Grb2 complex with two proteins in T cells: the guanine
nucleotide exchange protein Sos and a 75-kDa protein that is a substrate for
T cell antigen receptor-activated tyrosine kinases. J. Biol. Chem. 269:14081–
14087.
32. Reth, M. 1989. Antigen receptor tail clue. Nature (London) 338:383–384.
33. Rivero-Lezcano, O., J. Sameshima, A. Marcilla, and K. Robbins. 1994.
Physical association between src homology 3 elements and the protein prod-
uct of the c-cbl proto-oncogene. J. Biol. Chem. 269:17363–17366.
34. Rozakis-Adcock, M., J. McGlade, G. Mbamalu, G. Pelicci, R. Daly, W. Li, A.
Batzer, S. Thomas, J. Brugge, P. Pelicci, J. Schlessinger, and T. Pawson.
1992. Association of the Shc and Grb2/Sem 5 SH2-containing proteins is
implicated in activation of the Ras pathway by tyrosine kinases. Nature
(London) 360:689–692.
35. Rudd, C., O. Janssen, Y.-C. Cai, A. Silva, M. Raab, and K. Prasad. 1994.
Two-step TCR zeta/CD3-CD4 and CD28 signaling in T cells: SH2/SH3
domains, protein-tyrosine and lipid kinases. Immunol. Today 15:225–234.
35a.Samelson, L. Personal communication.
36. Samelson, L., A. Phillips, E. Luong, and R. Klausner. 1990. Association of
the fyn protein-tyrosine kinase with the T cell antigen receptor. Proc. Natl.
Acad. Sci. USA 87:4358–4363.
37. Samelson, L. E., and R. D. Klausner. 1992. Tyrosine kinases and tyrosine-
based activation motifs. Current research on activation via the T cell antigen
receptor. J. Biol. Chem. 267:24913–24916.
38. Seedorf, K., G. Kosta, R. Lammers, P. Bashkin, R. Daly, W. Burgess, A. van
der Bliek, J. Schlessinger, and A. Ullrich. 1994. Dynamin binds to SH3
domains of phospholipase Cg and Grb-2. J. Biol. Chem. 269:16009–16014.
39. Sieh, M., A. Batzer, J. Schlessinger, and A. Weiss. 1994. GRB2 and phos-
pholipase C-g1 associate with a 36- to 38-kilodalton phosphotyrosine protein
after T-cell receptor stimulation. Mol. Cell. Biol. 14:4435–4442.
40. Songyang, Z., S. E. Shoelson, J. McGlade, P. Olivier, T. Pawson, X. R.
Bustelo, M. Barbacid, H. Sabe, H. Hanafusa, T. Yi, R. Ren, D. Baltimore, S.
Ratnofsky, R. A. Feldman, and L. C. Cantley. 1994. Specific motifs recog-
nized by the SH2 domains of Csk, 3BP2, fps/fes, Grb2, HCP, SHC, Syk, and
Vav. Mol. Cell. Biol. 14:2777–2785.
41. Straus, D., and A. Weiss. 1993. The CD3 chain of the T cell antigen receptor
associates with the ZAP-70 tyrosine kinase and is tyrosine phosphorylated
after receptor stimulation. J. Exp. Med. 178:1523–1530.
42. Tanaka, S., T. Morishita, Y. Hashimoto, S. Hattori, S. Nakamura, M.
Shibuya, K. Matuoka, T. Takenawa, T. Kurata, K. Nagashima, and M.
Matsuda. 1994. C3G, a guanine nucleotide-releasing protein expressed ubiq-
uitously, binds to the Src homology 3 domains of CRK and GRB2/ASH
proteins. Proc. Natl. Acad. Sci. USA 91:3443–3447.
VOL. 15, 1995 Cbl BINDS TO PI 3-KINASE IN ACTIVATED T CELLS 3577
 at UNIV O
F M
ASS M
ED SCH on August 15, 2008 
m
cb.asm
.org
D
ow
nloaded from
 
43. Vogel, L. B., and D. J. Fujita. 1993. The SH3 domain of p56lck is involved in
binding to phosphatidylinositol 39-kinase from T lymphocytes. Mol. Cell.
Biol. 13:7408–7417.
44. Wang, L.-M., A. Keegan, L. Weiqun, G. Lienhard, S. Pacini, J. Gutkind, M.
Myers, Jr., X.-J. Sun, M. White, S. Aaronson, W. Paul, and J. Pierce. 1993.
Common elements in interleukin 4 and insulin signaling pathways in factor-
dependent hematopoietic cells. Proc. Natl. Acad. Sci. USA 90:4032–4036.
45. Ward, S., S. Ley, C. MacPhee, and D. Cantrell. 1992. Regulation of D-3
phosphoinositides during T cell activation via the T cell antigen receptor/
CD3 complex and CD2 antigens. Eur. J. Immunol. 22:45–49.
46. Weiss, A., and J. Imboden. 1987. Cell surface molecules and early events
involved in human T lymphocyte activation. Adv. Immunol. 41:1–38.
47. Weiss, A., and D. Littman. 1994. Signal transduction by lymphocyte antigen
receptors. Cell 7:263–274.
3578 MEISNER ET AL. MOL. CELL. BIOL.
 at UNIV O
F M
ASS M
ED SCH on August 15, 2008 
m
cb.asm
.org
D
ow
nloaded from
 
